Spinogenix Competitors and Similar CompaniesClear all
Spinogenix's competitors and similar companies include Regenevita, JCR Pharmaceuticals, GBT (Global Blood Therapeutics) and Travere Therapeutics.
 Spinogenix Spinogenix is a company that develops therapeutics restoring the brain connections and functions lost in brain injury and neurodegenerative diseases. |  Regenevita Regenevita BioCell is a company that provides regenerative medicine products and therapy commercialization services. |  JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. | |
Founding Date | Founding Date 2016 | Founding Date N/A | Founding Date 1975 | Founding Date 2012 | Founding Date 2011 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Houston, US HQ | Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations San Diego, US HQ Dublin, IE |
Employees | Employees 4 | Employees 3 | Employees 934 | Employees 352106% increase | Employees 46293% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 533.9 m | Valuation ($) 4.4 b | Valuation ($) 1.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥33.1b (FY, 2025) | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) $490.7m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥8b (FY, 2025) | Cost of goods $3.3m (FY, 2021) | Cost of goods $10.3m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥25.1b (FY, 2025) | Gross profit N/A | Gross profit $480.4m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income (¥4.7b) (FY, 2025) | Net income ($303.1m) (FY, 2021) | Net income ($25.5m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 88.7m | Total funding raised $ 25m |
For sources of this data, please see the company profile
View Company Profiles
Regenevita
HQ
Houston, US
Employees
3
Regenevita BioCell is a company that provides regenerative medicine products and therapy commercialization services.
View companyJCR Pharmaceuticals
HQ
Ashiya, JP
Employees
934
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
View companyGBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyTravere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View company